207 related articles for article (PubMed ID: 36814254)
1. The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children.
Amien R; Scott D; Verstraete J
Health Qual Life Outcomes; 2023 Feb; 21(1):19. PubMed ID: 36814254
[TBL] [Abstract][Full Text] [Related]
2. Performance of the EQ-5D-Y Interviewer Administered Version in Young Children.
Amien R; Scott D; Verstraete J
Children (Basel); 2022 Jan; 9(1):. PubMed ID: 35053718
[TBL] [Abstract][Full Text] [Related]
3. How does the EQ-5D-Y Proxy version 1 perform in 3, 4 and 5-year-old children?
Verstraete J; Lloyd A; Scott D; Jelsma J
Health Qual Life Outcomes; 2020 May; 18(1):149. PubMed ID: 32448278
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
[TBL] [Abstract][Full Text] [Related]
5. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
Verstraete J; Amien R; Scott D
Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
[TBL] [Abstract][Full Text] [Related]
6. Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.
Verstraete J; Booth C; Booth J; Peer S; McGuire J; Kritzinger F; Gray T; Zibi N; Shabangu P; Zampoli M
Patient; 2024 Jan; 17(1):65-82. PubMed ID: 37991685
[TBL] [Abstract][Full Text] [Related]
7. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
Scott D; Ferguson GD; Jelsma J
Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
[TBL] [Abstract][Full Text] [Related]
8. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
[TBL] [Abstract][Full Text] [Related]
9. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
[TBL] [Abstract][Full Text] [Related]
10. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
[TBL] [Abstract][Full Text] [Related]
12. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
[TBL] [Abstract][Full Text] [Related]
13. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
Fitriana TS; Purba FD; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
[TBL] [Abstract][Full Text] [Related]
15. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
16. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
17. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
[TBL] [Abstract][Full Text] [Related]
18. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
Khanna R; Jariwala K; Bentley JP
Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
[TBL] [Abstract][Full Text] [Related]
20. The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP).
Verstraete J; Scott D
Dialogues Health; 2022 Dec; 1():100032. PubMed ID: 38515901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]